•
Jun 30, 2014

EyePoint Pharmaceuticals Q4 2014 Earnings Report

Total Revenue
$292K
Previous year: $492K
-40.7%
EPS
-$1.4
Previous year: -$1.7
-17.6%
Gross Profit
$214K
Previous year: -$1.83M
-111.7%
Cash and Equivalents
$15.3M
Previous year: $6.9M
+122.3%
Total Assets
$22.7M
Previous year: $16.2M
+39.5%

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals